{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:06:33Z","timestamp":1789635993689,"version":"4.0.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010264","name":"Prevent Blindness","doi-asserted-by":"publisher","award":["GR004596"],"award-info":[{"award-number":["GR004596"]}],"id":[{"id":"10.13039\/100010264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJO International"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ajoint.2026.100311","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:01:07Z","timestamp":1788566467000},"page":"100311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prospective management of biopsy-proven ocular mucous membrane pemphigoid using an inflammation-oriented stepladder treatment strategy"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7311-7056","authenticated-orcid":false,"given":"Konstantina","family":"Bachtalia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4079-5998","authenticated-orcid":false,"given":"Veatriki","family":"Athanasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Athanasiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mavrommati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1601-9799","authenticated-orcid":false,"given":"Sotiria","family":"Palioura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoint.2026.100311_bib0001","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ajoint.2026.100311_bib0002","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jtos.2013.02.003","article-title":"Current medical treatment of ocular mucous membrane pemphigoid","volume":"11","author":"Sobolewska","year":"2013","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajoint.2026.100311_bib0003","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0161-6420(89)32942-3","article-title":"Glaucoma in patients with ocular cicatricial pemphigoid","volume":"96","author":"Tauber","year":"1989","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoint.2026.100311_bib0004","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/11206721231178110","article-title":"Survey: preferred practice patterns in the diagnosis of mucous membrane pemphigoid amongst cornea specialists","volume":"34","author":"Moussa","year":"2024","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajoint.2026.100311_bib0005","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajoint.2026.100311_bib0006","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00003226-199209000-00015","article-title":"Improved detection of disease progression in ocular cicatricial pemphigoid","volume":"11","author":"Tauber","year":"1992","journal-title":"Cornea"},{"key":"10.1016\/j.ajoint.2026.100311_bib0007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajo.2020.09.029","article-title":"Disease relapse after drug-free remission in ocular mucous membrane pemphigoid","volume":"223","author":"Shifera","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoint.2026.100311_bib0008","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/ICO.0b013e31826af7b8","article-title":"Treatment of mucous membrane pemphigoid with mycophenolate mofetil","volume":"32","author":"Nottage","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.ajoint.2026.100311_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.915205","article-title":"Rituximab therapy for mucous membrane pemphigoid: a retrospective monocentric study with long-term follow-up in 109 patients","volume":"13","author":"Bohelay","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajoint.2026.100311_bib0010","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/jdv.17395","article-title":"European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European academy of dermatology and venereology \u2013 Part II","volume":"35","author":"Schmidt","year":"2021","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.ajoint.2026.100311_bib0011","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ophtha.2017.10.004","article-title":"Mucous membrane pemphigoid with ocular involvement: the clinical phenotype and its relationship to direct immunofluorescence findings","volume":"125","author":"Ong","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoint.2026.100311_bib0012","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ophtha.2005.01.039","article-title":"Evaluation of mucous membrane pemphigoid with ocular involvement in young patients","volume":"112","author":"Rauz","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoint.2026.100311_bib0013","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaad.2017.05.016","article-title":"Multiple and repeated sampling increases the sensitivity of direct immunofluorescence testing for the diagnosis of mucous membrane pemphigoid","volume":"77","author":"Shimanovich","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ajoint.2026.100311_bib0014","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2007.04.027","article-title":"Immunosuppressive therapy for ocular mucous membrane pemphigoid. Strategies and outcomes","volume":"115","author":"Saw","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoint.2026.100311_bib0015","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ophtha.2024.02.028","article-title":"Ocular mucous membrane pemphigoid: the effect of risk factors at presentation on treatment outcomes","volume":"131","author":"Ruiz-Lozano","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoint.2026.100311_bib0016","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ophtha.2008.08.002","article-title":"Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy","volume":"115","author":"Thorne","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoint.2026.100311_bib0017","series-title":"Prescribing Information","author":"Rituxan","year":"2021"},{"key":"10.1016\/j.ajoint.2026.100311_bib0018","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.autrev.2017.05.017","article-title":"Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: an observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts","volume":"16","author":"Ruiz-Irastorza","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ajoint.2026.100311_bib0019","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"Kidney disease: improving global outcomes (KDIGO) lupus nephritis work group. KDIGO 2024 clinical practice guideline for the management of LUPUS NEPHRITIS","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajoint.2026.100311_bib0020","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2665-9913(21)00325-8","article-title":"Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the national COVID cohort collaborative","volume":"4","author":"Andersen","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ajoint.2026.100311_bib0021","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/S2665-9913(21)00418-5","article-title":"Rituximab during the COVID-19 pandemic: time to discuss treatment options with patients","volume":"4","author":"Boekel","year":"2022","journal-title":"Lancet Rheumatol"},{"issue":"232","key":"10.1016\/j.ajoint.2026.100311_bib0022","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/BF00181996","article-title":"The value of biopsies in the evaluation of chronic progressive conjunctival cicatrisation","volume":"232","author":"Bernauer","year":"1994","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol."},{"key":"10.1016\/j.ajoint.2026.100311_bib0023","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s00417-017-3603-3","article-title":"Rituximab in the treatment of ocular cicatricial pemphigoid: a retrospective cohort study","volume":"255","author":"You","year":"2017","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol."},{"key":"10.1016\/j.ajoint.2026.100311_bib0024","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.3390\/jcm11144102","article-title":"Rituximab in mucous membrane pemphigoid: a monocentric retrospective study in 10 patients with severe\/refractory disease","volume":"11","author":"Baffa","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajoint.2026.100311_bib0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jtos.2019.10.010","article-title":"Validation of a clinical assessment tool for cicatrising conjunctivitis","volume":"18","author":"Ong","year":"2020","journal-title":"Ocul Surf"}],"container-title":["AJO International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950253526000882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950253526000882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:53:46Z","timestamp":1789635226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950253526000882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2950253526000882"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoint.2026.100311","relation":{},"ISSN":["2950-2535"],"issn-type":[{"value":"2950-2535","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective management of biopsy-proven ocular mucous membrane pemphigoid using an inflammation-oriented stepladder treatment strategy","name":"articletitle","label":"Article Title"},{"value":"AJO International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoint.2026.100311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100311"}}